DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens

Abstract

The continued rise and spread of antimicrobial resistance among bacterial pathogens pose a serious challenge to global health. Countering antimicrobial-resistant pathogens requires a multifaceted effort that includes the discovery of novel therapeutic approaches. Here, we establish the capacity of the human CXC chemokines CXCL9 and CXCL10 to kill multidrug-resistant Gram-negative bacteria, including New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae and colistin-resistant members of the family Enterobacteriaceae that harbor the mobile colistin resistance protein MCR-1 and thus possess phosphoethanolamine-modified lipid A. Colistin-resistant K. pneumoniae isolates affected by genetic mutation of the PmrA/PmrB two-component system, a chromosomally encoded regulator of lipopolysaccharide modification, and containing 4-amino-4-deoxy-L-arabinose-modified lipid A were also found to be susceptible to chemokine-mediated antimicrobial activity. However, loss of PhoP/PhoQ autoregulatory control, caused by disruption of the gene encoding the negative regulator MgrB, limited the bactericidal effects of CXCL9 and CXCL10 in a variable, strain-specific manner. Cumulatively, these findings provide mechanistic insight into chemokine-mediated antimicrobial activity, highlight disparities amongst determinants of colistin resistance, and suggest that chemokine-mediated bactericidal effects merit additional investigation as a therapeutic avenue for treating infections caused by multidrug-resistant pathogens.

Authors:
 [1];  [2];  [3];  [4];  [5];  [6];  [6];  [7];  [8];  [9];  [4];  [4];  [10];  [3];  [1];
  1. Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia (United States)
  2. Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, VA (United States)
  3. Department of Microbial Pathogenesis, School of Dentistry, University of Maryland-Baltimore, Baltimore, Maryland (United States)
  4. Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland (United States)
  5. National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (United States)
  6. Department of Medical Biotechnologies, University of Siena, Siena (Italy)
  7. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Microbiology and Virology Unit, Florence Careggi University Hospital, Florence (Italy)
  8. Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (United States)
  9. Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland—Baltimore, Baltimore, Maryland (United States)
  10. Department of Pathology and Microbiology, Aga Khan University, Karachi (Pakistan)
Publication Date:
Research Org.:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE; National Institute of Health; US Food and Drug Administration; U.S. Department of Homeland Security Science and Technology Directorate
OSTI Identifier:
1626135
Grant/Contract Number:  
SC0014664; R01 AI099097; F32 AI108249; HSHQPM-16-X- 00066
Resource Type:
Accepted Manuscript
Journal Name:
mBio (Online)
Additional Journal Information:
Journal Name: mBio (Online); Journal Volume: 8; Journal Issue: 6; Journal ID: ISSN 2150-7511
Publisher:
American Society for Microbiology (ASM)
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Microbiology

Citation Formats

Crawford, Matthew A., Fisher, Debra J., Leung, Lisa M., Lomonaco, Sara, Lascols, Christine, Cannatelli, Antonio, Giani, Tommaso, Rossolini, Gian Maria, Doi, Yohei, Goodlett, David R., Allard, Marc W., Sharma, Shashi K., Khan, Erum, Ernst, Robert K., Hughes, Molly A., and Bush, Karen. CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens. United States: N. p., 2017. Web. doi:10.1128/mbio.01549-17.
Crawford, Matthew A., Fisher, Debra J., Leung, Lisa M., Lomonaco, Sara, Lascols, Christine, Cannatelli, Antonio, Giani, Tommaso, Rossolini, Gian Maria, Doi, Yohei, Goodlett, David R., Allard, Marc W., Sharma, Shashi K., Khan, Erum, Ernst, Robert K., Hughes, Molly A., & Bush, Karen. CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens. United States. https://doi.org/10.1128/mbio.01549-17
Crawford, Matthew A., Fisher, Debra J., Leung, Lisa M., Lomonaco, Sara, Lascols, Christine, Cannatelli, Antonio, Giani, Tommaso, Rossolini, Gian Maria, Doi, Yohei, Goodlett, David R., Allard, Marc W., Sharma, Shashi K., Khan, Erum, Ernst, Robert K., Hughes, Molly A., and Bush, Karen. Tue . "CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens". United States. https://doi.org/10.1128/mbio.01549-17. https://www.osti.gov/servlets/purl/1626135.
@article{osti_1626135,
title = {CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens},
author = {Crawford, Matthew A. and Fisher, Debra J. and Leung, Lisa M. and Lomonaco, Sara and Lascols, Christine and Cannatelli, Antonio and Giani, Tommaso and Rossolini, Gian Maria and Doi, Yohei and Goodlett, David R. and Allard, Marc W. and Sharma, Shashi K. and Khan, Erum and Ernst, Robert K. and Hughes, Molly A. and Bush, Karen},
abstractNote = {The continued rise and spread of antimicrobial resistance among bacterial pathogens pose a serious challenge to global health. Countering antimicrobial-resistant pathogens requires a multifaceted effort that includes the discovery of novel therapeutic approaches. Here, we establish the capacity of the human CXC chemokines CXCL9 and CXCL10 to kill multidrug-resistant Gram-negative bacteria, including New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae and colistin-resistant members of the family Enterobacteriaceae that harbor the mobile colistin resistance protein MCR-1 and thus possess phosphoethanolamine-modified lipid A. Colistin-resistant K. pneumoniae isolates affected by genetic mutation of the PmrA/PmrB two-component system, a chromosomally encoded regulator of lipopolysaccharide modification, and containing 4-amino-4-deoxy-L-arabinose-modified lipid A were also found to be susceptible to chemokine-mediated antimicrobial activity. However, loss of PhoP/PhoQ autoregulatory control, caused by disruption of the gene encoding the negative regulator MgrB, limited the bactericidal effects of CXCL9 and CXCL10 in a variable, strain-specific manner. Cumulatively, these findings provide mechanistic insight into chemokine-mediated antimicrobial activity, highlight disparities amongst determinants of colistin resistance, and suggest that chemokine-mediated bactericidal effects merit additional investigation as a therapeutic avenue for treating infections caused by multidrug-resistant pathogens.},
doi = {10.1128/mbio.01549-17},
journal = {mBio (Online)},
number = 6,
volume = 8,
place = {United States},
year = {Tue Nov 14 00:00:00 EST 2017},
month = {Tue Nov 14 00:00:00 EST 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Figures / Tables:

FIG 1 FIG 1: Bactericidal effects of CXC chemokines against CRE. (A) Carbapenem-resistant K. pneumoniae isolates and a species-matched control (ATCC 43816) are shown. Multilocus sequence types (MLSTs) and genes encoding the NDM-1 and/or OXA-48 carbapenemases are indicated. Antimicrobial susceptibilities (reported as MIC [ μg/ml]) were interpreted as resistant (red) or susceptiblemore » (green) in accordance with established breakpoints. The antibiotics tested were ampicillin (AMP), amoxicillin-clavulanic acid (AMC), AMP-sulbactam (SAM), piperacillin-tazobactam (TZP), cefazolin (CFZ), cefoxitin (FOX), cefotaxime (CTX), ceftriaxone (CRO), aztreonam (ATM), cefepime (FEP), ertapenem (ERT), doripenem (DOR), imipenem (IPM), meropenem (MEM), CST, amikacin (AMK), gentamicin (GEN), tobramycin (TOB), ciprofloxacin (CIP), levofloxacin (LVX), tetracycline (TET), tigecycline (TGC), and trimethoprim-sulfamethoxazole (SXT). Bacteria were treated with 48 μg/ml CXCL10 (B) or CXCL9 (C), and survival was measured by CFU determination (limit of detection, 500 CFU/ml; n.d., none detected). Data are expressed as percentages of the respective untreated-control value and represent the mean the standard error of the mean (n = 3). *, P < 0.05; **, P < 0.01 (compared to ATCC 43816). (D) CRE isolate BL12125 was treated with increasing concentrations of CXCL10. Data are expressed as percentages of the untreated-control value and represent the mean ± the standard error of the mean (n = 3). ***, P < 0.001 (compared to the untreated control).« less

Save / Share:

Works referenced in this record:

Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
journal, January 2015

  • Yu, Zhiliang; Qin, Wangrong; Lin, Jianxun
  • BioMed Research International, Vol. 2015
  • DOI: 10.1155/2015/679109

Membrane anchoring stabilizes and favors secretion of New Delhi metallo-β-lactamase
journal, May 2016

  • González, Lisandro J.; Bahr, Guillermo; Nakashige, Toshiki G.
  • Nature Chemical Biology, Vol. 12, Issue 7
  • DOI: 10.1038/nchembio.2083

Antimicrobial Effects of Interferon-Inducible CXC Chemokines against Bacillus anthracis Spores and Bacilli
journal, January 2009

  • Crawford, Matthew A.; Zhu, Yinghua; Green, Candace S.
  • Infection and Immunity, Vol. 77, Issue 4
  • DOI: 10.1128/IAI.01208-08

Antimicrobial peptides of multicellular organisms
journal, January 2002


Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
journal, June 2013

  • Needham, Brittany D.; Trent, M. Stephen
  • Nature Reviews Microbiology, Vol. 11, Issue 7
  • DOI: 10.1038/nrmicro3047

Antimicrobial Chemokines
journal, January 2012


ISfinder: the reference centre for bacterial insertion sequences
journal, January 2006


Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria
journal, June 2017


Transcriptional analysis of bla NDM-1 and copy number alteration under carbapenem stress
journal, February 2017

  • Paul, Deepjyoti; Bhattacharjee, Amitabha; Bhattacharjee, Dibyojyoti
  • Antimicrobial Resistance & Infection Control, Vol. 6, Issue 1
  • DOI: 10.1186/s13756-017-0183-2

Dissecting the PhoP regulatory network of Escherichia coli and Salmonella enterica
journal, February 2005

  • Zwir, I.; Shin, D.; Kato, A.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 8
  • DOI: 10.1073/pnas.0408238102

Feedback Inhibition in the PhoQ/PhoP Signaling System by a Membrane Peptide
journal, December 2009


Many chemokines including CCL20/MIP-3α display antimicrobial activity
journal, June 2003

  • Yang, De; Chen, Qian; Hoover, David M.
  • Journal of Leukocyte Biology, Vol. 74, Issue 3
  • DOI: 10.1189/jlb.0103024

Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
journal, January 2014

  • Dortet, Laurent; Poirel, Laurent; Nordmann, Patrice
  • BioMed Research International, Vol. 2014
  • DOI: 10.1155/2014/249856

Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis
journal, September 2011

  • Crawford, M. A.; Lowe, D. E.; Fisher, D. J.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 41
  • DOI: 10.1073/pnas.1108495108

Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)
journal, June 2011

  • Lascols, C.; Hackel, M.; Marshall, S. H.
  • Journal of Antimicrobial Chemotherapy, Vol. 66, Issue 9
  • DOI: 10.1093/jac/dkr240

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
journal, November 2014


Interferon-Inducible CXC Chemokines Directly Contribute to Host Defense against Inhalational Anthrax in a Murine Model of Infection
journal, November 2010


Deciphering tissue-induced Klebsiella pneumoniae lipid A structure
journal, November 2015

  • Llobet, Enrique; Martínez-Moliner, Verónica; Moranta, David
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 46
  • DOI: 10.1073/pnas.1508820112

Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens
journal, April 2017

  • Liu, Yi-Yun; Chandler, Courtney E.; Leung, Lisa M.
  • Antimicrobial Agents and Chemotherapy, Vol. 61, Issue 6
  • DOI: 10.1128/AAC.00580-17

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
journal, February 2016


Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
journal, November 2014


CCL28 Has Dual Roles in Mucosal Immunity as a Chemokine with Broad-Spectrum Antimicrobial Activity
journal, February 2003


Evolution and Dynamics of Regulatory Architectures Controlling Polymyxin B Resistance in Enteric Bacteria
journal, October 2008


Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria
journal, June 2017


Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
journal, October 1998


Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniae
journal, March 2016


Antimicrobial peptides of multicellular organisms
journal, January 2002


Membrane anchoring stabilizes and favors secretion of New Delhi metallo-β-lactamase
journal, May 2016

  • González, Lisandro J.; Bahr, Guillermo; Nakashige, Toshiki G.
  • Nature Chemical Biology, Vol. 12, Issue 7
  • DOI: 10.1038/nchembio.2083

Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
journal, June 2013

  • Needham, Brittany D.; Trent, M. Stephen
  • Nature Reviews Microbiology, Vol. 11, Issue 7
  • DOI: 10.1038/nrmicro3047

Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis
journal, September 2011

  • Crawford, M. A.; Lowe, D. E.; Fisher, D. J.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 41
  • DOI: 10.1073/pnas.1108495108

Deciphering tissue-induced Klebsiella pneumoniae lipid A structure
journal, November 2015

  • Llobet, Enrique; Martínez-Moliner, Verónica; Moranta, David
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 46
  • DOI: 10.1073/pnas.1508820112

Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)
journal, June 2011

  • Lascols, C.; Hackel, M.; Marshall, S. H.
  • Journal of Antimicrobial Chemotherapy, Vol. 66, Issue 9
  • DOI: 10.1093/jac/dkr240

Resistance to Colistin Associated with a Single Amino Acid Change in Protein PmrB among Klebsiella pneumoniae Isolates of Worldwide Origin
journal, June 2014

  • Jayol, Aurélie; Poirel, Laurent; Brink, Adrian
  • Antimicrobial Agents and Chemotherapy, Vol. 58, Issue 8
  • DOI: 10.1128/aac.00084-14

First Detection of the mcr-1 Colistin Resistance Gene in Escherichia coli in Italy
journal, March 2016

  • Cannatelli, Antonio; Giani, Tommaso; Antonelli, Alberto
  • Antimicrobial Agents and Chemotherapy, Vol. 60, Issue 5
  • DOI: 10.1128/aac.00246-16

mcr-1.2 , a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512
journal, July 2016

  • Di Pilato, Vincenzo; Arena, Fabio; Tascini, Carlo
  • Antimicrobial Agents and Chemotherapy, Vol. 60, Issue 9
  • DOI: 10.1128/aac.01075-16

In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator
journal, August 2013

  • Cannatelli, Antonio; D'Andrea, Marco Maria; Giani, Tommaso
  • Antimicrobial Agents and Chemotherapy, Vol. 57, Issue 11
  • DOI: 10.1128/aac.01480-13

MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin
journal, July 2014

  • Cannatelli, Antonio; Giani, Tommaso; D'Andrea, Marco Maria
  • Antimicrobial Agents and Chemotherapy, Vol. 58, Issue 10
  • DOI: 10.1128/aac.03110-14

Genome Sequences of Multidrug-Resistant, Colistin-Susceptible and -Resistant Klebsiella pneumoniae Clinical Isolates from Pakistan
journal, December 2016


Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity
journal, November 2015

  • Schutte, Kirsten M.; Fisher, Debra J.; Burdick, Marie D.
  • Infection and Immunity, Vol. 84, Issue 1
  • DOI: 10.1128/iai.00552-15

CXCL10 Acts as a Bifunctional Antimicrobial Molecule against Bacillus anthracis
journal, May 2016

  • Margulieux, Katie R.; Fox, Jay W.; Nakamoto, Robert K.
  • mBio, Vol. 7, Issue 3
  • DOI: 10.1128/mbio.00334-16

Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
journal, January 2015

  • Yu, Zhiliang; Qin, Wangrong; Lin, Jianxun
  • BioMed Research International, Vol. 2015
  • DOI: 10.1155/2015/679109

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
journal, November 2014


Transcriptional analysis of bla NDM-1 and copy number alteration under carbapenem stress
journal, February 2017

  • Paul, Deepjyoti; Bhattacharjee, Amitabha; Bhattacharjee, Dibyojyoti
  • Antimicrobial Resistance & Infection Control, Vol. 6, Issue 1
  • DOI: 10.1186/s13756-017-0183-2

Many chemokines including CCL20/MIP-3α display antimicrobial activity
journal, June 2003

  • Yang, De; Chen, Qian; Hoover, David M.
  • Journal of Leukocyte Biology, Vol. 74, Issue 3
  • DOI: 10.1189/jlb.0103024

Microextraction of bacterial lipid A: easy and rapid method for mass spectrometric characterization
journal, June 2005


Evolution and Dynamics of Regulatory Architectures Controlling Polymyxin B Resistance in Enteric Bacteria
journal, October 2008


Feedback Inhibition in the PhoQ/PhoP Signaling System by a Membrane Peptide
journal, December 2009


Interferon-Inducible CXC Chemokines Directly Contribute to Host Defense against Inhalational Anthrax in a Murine Model of Infection
journal, November 2010


CCL28 Has Dual Roles in Mucosal Immunity as a Chemokine with Broad-Spectrum Antimicrobial Activity
journal, February 2003


Works referencing / citing this record:

Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates
journal, June 2018


Mechanistic insights and therapeutic opportunities of antimicrobial chemokines
journal, April 2019

  • Crawford, Matthew A.; Margulieux, Katie R.; Singh, Arpita
  • Seminars in Cell & Developmental Biology, Vol. 88
  • DOI: 10.1016/j.semcdb.2018.02.003

Figures/Tables have been extracted from DOE-funded journal article accepted manuscripts.